Bahl & Gaynor Inc Simulations Plus, Inc. Transaction History

Bahl & Gaynor Inc

$19.3 Billion
Q3 2024

A detailed history of Bahl & Gaynor Inc transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Bahl & Gaynor Inc holds 14,400 shares of SLP stock, worth $451,152. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,400

Previous 14,500 0.69%

Holding current value

$451,152

Previous $704,000 34.66%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$30.46 - $46.86 $3,046 - $4,686	-100 Reduced 0.69%	14,400 $460,000
Q4 2023 Feb 02, 2024	BUY	$33.36 - $45.71 $118,428 - $162,270	3,550 Added 32.42%	14,500 $648,000
Q4 2022 Feb 10, 2023	BUY	$36.55 - $51.15 $54,824 - $76,725	1,500 Added 15.87%	10,950 $400,000
Q2 2022 Aug 08, 2022	SELL	$40.55 - $51.76 $1,500 - $1,915	-37 Reduced 0.39%	9,450 $466,000
Q1 2022 May 12, 2022	SELL	$36.56 - $50.98 $5,484 - $7,646	-150 Reduced 1.56%	9,487 $484,000
Q4 2021 Feb 10, 2022	SELL	$37.1 - $57.45 $687,500 - $1.06 Million	-18,531 Reduced 65.79%	9,637 $456,000
Q3 2021 Nov 15, 2021	SELL	$38.45 - $55.66 $1.03 Million - $1.48 Million	-26,661 Reduced 48.63%	28,168 $1.11 Million
Q2 2021 Aug 06, 2021	SELL	$49.67 - $68.96 $145,284 - $201,707	-2,925 Reduced 5.06%	54,829 $3.01 Million
Q1 2021 May 11, 2021	SELL	$60.06 - $89.52 $1.98 Million - $2.96 Million	-33,050 Reduced 36.4%	57,754 $3.65 Million
Q4 2020 Feb 02, 2021	SELL	$53.26 - $77.18 $14,539 - $21,070	-273 Reduced 0.3%	90,804 $6.53 Million
Q3 2020 Nov 12, 2020	SELL	$57.51 - $75.36 $821,587 - $1.08 Million	-14,286 Reduced 13.56%	91,077 $6.86 Million
Q2 2020 Aug 13, 2020	SELL	$32.91 - $59.82 $60,258 - $109,530	-1,831 Reduced 1.71%	105,363 $6.3 Million
Q1 2020 May 26, 2020	BUY	$26.79 - $38.99 $2.87 Million - $4.18 Million	107,194 New	107,194 $3.74 Million
Q1 2020 May 15, 2020	SELL	$26.79 - $38.99 $2.84 Million - $4.13 Million	-105,874 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$29.07 - $35.63 $5,000 - $6,128	-172 Reduced 0.16%	105,874 $3.08 Million
Q3 2019 Nov 14, 2019	SELL	$28.19 - $41.75 $506,461 - $750,080	-17,966 Reduced 14.49%	106,046 $3.68 Million
Q2 2019 Aug 12, 2019	BUY	$19.91 - $28.97 $238,282 - $346,712	11,968 Added 10.68%	124,012 $3.54 Million
Q1 2019 May 13, 2019	BUY	$18.84 - $21.36 $55,163 - $62,542	2,928 Added 2.68%	112,044 $2.37 Million
Q4 2018 Feb 12, 2019	SELL	$17.56 - $21.2 $137,846 - $166,420	-7,850 Reduced 6.71%	109,116 $2.17 Million
Q3 2018 Nov 09, 2018	BUY	$17.1 - $23.55 $328,986 - $453,078	19,239 Added 19.69%	116,966 $2.36 Million
Q2 2018 Aug 14, 2018	BUY	$14.65 - $23.75 $481,149 - $780,021	32,843 Added 50.62%	97,727 $2.17 Million
Q1 2018 May 11, 2018	BUY	$14.4 - $16.8 $13,089 - $15,271	909 Added 1.42%	64,884 $957,000
Q4 2017 Feb 13, 2018	BUY	$15.3 - $17.4 $53,320 - $60,638	3,485 Added 5.76%	63,975 $1.03 Million
Q3 2017 Nov 13, 2017	BUY	$13.7 - $15.65 $147,686 - $168,707	10,780 Added 21.69%	60,490 $937,000
Q2 2017 Aug 11, 2017	BUY	N/A	49,710	49,710 $614,000

Others Institutions Holding SLP

# of Institutions

176

Shares Held

15.2M

Call Options Held

5.4K

Put Options Held

1.4K

View Full List

About Simulations Plus, Inc.

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $636M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

More about SLP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.

Account